Alok Khorana: Six Years of Growth and Transformation at National Blood Clot Alliance
Alok Khorana, Vice Chair of the Taussig Cancer Institute at Cleveland Clinic, shared a post on LinkedIn:
“It’s been a dynamic six years of growth and transformation as I reach the end of my second and final term as Chair of the Medical and Scientific Advisory Board of National Blood Clot Alliance. From creating the Council for Emerging Researchers in Thrombosis (CERT) to effective public policy advances at state and federal levels such as the passage of the Emily Adkins Act in Florida, I couldn’t have asked for a better partner than Leslie Lake. She is an inspirational leader who has changed the boundaries of what’s possible in this patient-led organization.
I’m excited to hand off leadership to incoming Chair Jeffrey Zwicker who I’m absolutely confident will lead the Board to newer and greater heights.
Finally, I’m absolutely delighted to remain involved with MASAB and NBCA as Chair Emeritus. Much has been done to alleviate the public health and individual burden of thromboembolism but much remains to be done.”
Stay updated with Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’